Vevorisertib trihydrochloride
Vevorisertib trihydrochloride is a potent, selective pan-AKT inhibitor that also targets the AKT1-E17K mutant. It is used in research for advanced solid tumors and hepatocellular carcinoma, with studies demonstrating its activity in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1416775-08-0
Product Name Alternative
ARQ751 Trihydrochloride, ARQ-751 Trihydrochloride, ARQ751, ARQ-751, ARQ 751, ARQ 751 trihydrochloride, Akt, P-Akt, Vevorisertib trihydrochloride, Vevorisertib
Field of Research
Signal Transduction
Purity
98.28% (May vary between batches)
Solubility
DMSO:100 mg/mL (143.65 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (7.18 mM) ; H2O:20 mg/mL (28.73 mM)
Smiles
Cl.Cl.Cl.CN (C1CCN (CC1) c1cccc (c1) -c1ccc2nc (-c3cccnc3N) n (-c3ccc (cc3) C3 (N) CCC3) c2n1) C (C) =O
Molecular Formula
C35H41Cl3N8O
Molecular Weight
696.12
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
